Safety and Efficacy of NAFT900 in Children With Tinea Capitis

NCT02658292 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Tinea Capitis

Interventions

DRUG: Naftifine hydrochloride foam, 3%
DRUG: Vehicle

Sponsor

Merz North America, Inc.